Fig. 1From: Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancerComparison of the overall survival between immunotherapy and conventional chemotherapy in male, female, and overall population. C, chemotherapy; CI, confidence interval; HR, hazard ratio; I, ipilimumab; N, nivolumabBack to article page